Arthur He
Stock Analyst at HC Wainwright & Co.
(4.48)
# 286
Out of 5,156 analysts
49
Total ratings
57.69%
Success rate
30.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERA Vera Therapeutics | Maintains: Buy | $90 → $110 | $39.07 | +181.55% | 4 | Mar 2, 2026 | |
| NKTR Nektar Therapeutics | Maintains: Buy | $135 → $165 | $70.70 | +133.38% | 6 | Feb 10, 2026 | |
| JBIO Jade Biosciences | Initiates: Buy | $25 | $14.05 | +77.94% | 1 | Jan 7, 2026 | |
| ADAG Adagene | Maintains: Buy | $8 → $7 | $2.84 | +146.48% | 11 | Aug 15, 2025 | |
| AUPH Aurinia Pharmaceuticals | Assumes: Buy | $17 | $14.32 | +18.72% | 1 | Jul 30, 2025 | |
| SLDB Solid Biosciences | Reiterates: Buy | $20 | $6.75 | +196.30% | 10 | Jun 17, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | n/a | $4.01 | - | 8 | May 20, 2025 | |
| BCAB BioAtla | Reiterates: Neutral | n/a | $0.17 | - | 8 | Mar 31, 2025 |
Vera Therapeutics
Mar 2, 2026
Maintains: Buy
Price Target: $90 → $110
Current: $39.07
Upside: +181.55%
Nektar Therapeutics
Feb 10, 2026
Maintains: Buy
Price Target: $135 → $165
Current: $70.70
Upside: +133.38%
Jade Biosciences
Jan 7, 2026
Initiates: Buy
Price Target: $25
Current: $14.05
Upside: +77.94%
Adagene
Aug 15, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $2.84
Upside: +146.48%
Aurinia Pharmaceuticals
Jul 30, 2025
Assumes: Buy
Price Target: $17
Current: $14.32
Upside: +18.72%
Solid Biosciences
Jun 17, 2025
Reiterates: Buy
Price Target: $20
Current: $6.75
Upside: +196.30%
Prime Medicine
May 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.01
Upside: -
BioAtla
Mar 31, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.17
Upside: -